CPDD Program https://www.xcdsystem.com/cpdd/printedProgram/program.cfm Saturday, June 17, 2017 REGISTRATION Bottom of escalator 1:00 - 5:30 PM (PRE-REGISTRANTS ONLY) Fontaine A & B NIDA GRANT-WRITING 1:00 - 5:30 PM OPENING RECEPTION Salon Bonaventure & Ville-Marie 7:00 - 9:00 PM Sunday, June 18, 2017 PLENARY Montreal Ballroom 8:30 - 11:00 AM 8:30 Welcome 8:40 Report from the National Institute on Drug Abuse: Drug Abuse and Addiction Research: Progress, Priorities and Challenges 9:10 Report from the National Institute on Alcohol Abuse and Alcoholism: NIAAA Update: Priorities Going Forward 9:40 Presentation of the Stephen G. Holtzman Travel Award for Preclinical Investigators to Jibran Y. Khokhar 9:50 Presentation of the CPDD/NIDA Media Award to Sam Quinones 10:05 Presentation of the Joseph Cochin Young Investigator Award to Matthew Banks 10:15 Presentation of the Mentorship Award to Stephen T. Higgins 1 of 109 6/2/17, 3:34 PM CPDD Program https://www.xcdsystem.com/cpdd/printedProgram/program.cfm 10:25 Presentation of the Nathan B. Eddy Award to Walter Ling 10:40 Nathan B. Eddy Lecture: Accidents and Angels: The Man Who Got His Life Philosophy from a Bottle Cap (BY INVITATION) Salon Ville-Marie CPDD TRAVEL AWARDS LUNCHEON 11:30 - 1:00 PM PRESIDENT'S SYMPOSIUM Westmount/Outremont ENHANCING RESEARCH ON CONTROLLED SUBSTANCES 1:00 - 2:30 PM 1:00 Introduction 1:05 William Dewey 1:10 Perspective from NIDA 1:15 Perspective from FDA 1:20 Perspective from DEA 1:25 Perspective from a researcher 1:30 Questions and comments from audience ORAL COMMUNICATIONS 1 Mont-Royal DISPARITÉS EN MATIÈRE DE SANTÉ: HEALTH DISPARITIES 2:45 - 4:45 PM Chairs: Qiana Brown and Anna Pagano 2:45 The use of the Black Church to improve treatment access for Blacks with SUD A. Jordan, Yale University, New Haven , CT 3:00 Exploring factors related to uptake of oral pre-exposure prophylaxis among Black women with substance use problems Keosha Bond1, Alana Gunn2, Porche Williams3 , 1NYU Rory Meyers College of Nursing, New York, NY, 2Binghamton University, Binghamton, NY, 3National Development and Research Institute, Inc., New York, NY 3:15 Model minorities? Asian-American trauma and drug use Tanya Saraiya1, Denise Hien2, Aimee Campbell3 , 1TRACC Program, Brooklyn, NY, 2Adelphi University, Garden City, NY, 2 of 109 6/2/17, 3:34 PM CPDD Program https://www.xcdsystem.com/cpdd/printedProgram/program.cfm 3Columbia University and NYSPI, New York, NY 3:30 Prenatal marijuana use, psychiatric comorbidity, and vulnerable populations in the U.S. Qiana Brown1, Aaron Sarvet2, Deborah Hasin2 , 1Columbia University Mailman School of Public Health, Newark, NJ, 2Columbia University, New York, NY 3:45 Cannabis motives and social anxiety: Effects of race and gender in cannabis use and problems among young adults Dawn Foster1, Ecker Anthony2, Kraus Shane3, Stephanie O'Malley4, Kristin Dukes5, Gretchen Blycker6, Carolyn Sartor4 , 1Yale University, New Haven, CT, 2Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, 3Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, 4Yale School of Medicine, New Haven, CT, 5Simmons College, Boston, MA, 6University of Rhode Island, Kingston, RI 4:00 Predictors of smoking behaviors among Latinos in substance abuse treatment Anna Pagano1, Noah Gubner2, Thao Le2, Barbara Tajima3, Joseph Guydish2 , 1Prevention Research Center, Oakland, CA, 2UCSF, San Francsico, CA, 3UCSF, San Francisco, CA 4:15 Cultural predictors of intimate partner violence perpetration and victimization in Latino emerging adults Carolina Villamil Grest1, Hortensia Amaro2, Jennifer Unger1 , 1University of Southern California, Los Angeles, CA, 2ISC School of Social Work, Los Angeles, CA 4:30 Racial and ethnic disparities in opioid agonist treatment for opioid use disorder in a U.S. national sample Noa Krawczyk1, Kenneth Feder2, Brendan Saloner2 , 1Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, Baltimore, MD, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ORAL COMMUNICATIONS 2 Verdun THE ODD COUPLE: DRUG INTERACTIONS 2:45 - 4:45 PM Chairs: Sally Huskinson and Emily Jutkiewicz 2:45 Ethanol reversal of prescription opioid tolerance Laura Johnson1, Hamid Akbarali1, Graeme Henderson2, William Dewey1 , 1Virginia Commonwealth University, Richmond, VA, 2University of Bristol, Bristol, UK 3:00 A sex comparison of morphine and delta-9-tetrahydrocannabinol interactions on inflammatory pain in rats Stevie Britch1, Carlie Knox1, Jenny Wiley2, Rebecca Craft1 , 1Washington State University, Pullman, WA, 2RTI International, Research Triangle Park, NC 3:15 Adolescent delta(9)-tetrahydrocannabinol exposure enhances sensitivity to the reinforcing effects of cocaine 3 of 109 6/2/17, 3:34 PM CPDD Program https://www.xcdsystem.com/cpdd/printedProgram/program.cfm Emily Jutkiewicz1, Amy Friedman2 , 1University of Michigan, Ann Arbor, MI, 2Wayne State University, Detroit, MI 3:30 Abuse-related effects of mixtures of cocaine and caffeine in rats Brenda Gannon1, Kayla Galindo1, Melson Mesmin1, Kenner Rice2, Gregory Collins1 , 1University of Texas Health Science Center, San Antonio, TX, 2NIH, NIDA, Rockville, MD 3:45 Endorsing cannabis as drug of choice is associated with increased use of other illicit drugs: A longitudinal analysis Jesse Hinckley1, Christian Hopfer2, Michael Stallings3, John Hewitt3, Susan Young1 , 1University of Colorado School of Medicine, Department of Psychiatry, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO, 3University of Colorado, Denver, CO 4:00 Self-administration of benzodiazepine and cocaine combinations by monkeys in a choice procedure: Role of GABA-A receptor subtypes Sally Huskinson1, Kevin Freeman1, James Rowlett1 , 1University of Mississippi Medical Center, Jackson, MS 4:15 Cannabinoid modulation of the analgesic effects of opioids in humans Shanna Babalonis1, Michelle Lofwall2, Paul Sloan1, Paul Nuzzo1, Laura Fanucchi1, Sharon Walsh1 , 1University of Kentucky, Lexington, KY, 2University of Kentucky College of Medicine, Lexington, KY 4:30 The influence of mentholation on usual brand and research cigarettes of varying nicotine content in vulnerable populations Danielle Davis1, Cecilia Bergeria1, Joanna Streck2, Janice Bunn1, Diann Gaalema3, Sarah Heil1, Stacey Sigmon1, Maxine Stitzer4, Jennifer Tidey5, Stephen Higgins1 , 1University of Vermont, Burlington, VT, 2Vermont Center on Behavior and Health, Burlington, VT, 3University of Vermont UHC Campus, Burlington, VT, 4Johns Hopkins Bayview Medical Center, Baltimore, MD, 5Brown University School of Medicine, Providence, RI SYMPOSIUM I Westmount WHAT IS THE ROLE OF SLEEP IN SUBSTANCE USE? 2:45 - 4:45 PM EVIDENCE FROM STUDIES OF CANNABIS, ALCOHOL, AND OPIOID USE Chairs: Patrick Finan and Brant Hasler 2:45 Mechanisms of sleep disturbance in individuals with opioid use disorder P. Finan, Johns Hopkins University, Baltimore, MD 3:10 Sleep and circadian function in adolescents and young adults who use alcohol B. Hasler, University of Pittsburgh, Pittsburgh, PA 4 of 109 6/2/17, 3:34 PM CPDD Program https://www.xcdsystem.com/cpdd/printedProgram/program.cfm 3:35 Subjective and objective assessment of sleep in treatment-seeking cannabis users D. Lee, Johns Hopkins Medicine, Lexington, KY 4:00 Sleep and substance use: Effects at varying frequencies of use among cannabis and alcohol users D. Conroy, University of Michigan, Ann Arbor, MI 4:25 DISCUSSANT: Methodological considerations in sleep research among individuals with substance use disorder P. Morgan, Yale School of Medicine, New Haven, CT SYMPOSIUM II Outremont TRANSLATIONAL APPROACHES TO UNCOVERING THE 2:45 - 4:45 PM MECHANISMS UNDERLYING NEONATAL ABSTINENCE SYNDROME Chairs: Lisa Brents and Jessica Coker 2:45 The impact of antenatal buprenorphine use on fetal neurobehavioral profile, obstetrical course, and neonatal outcome J. Coker, University of Arkansas for Medical Sciences, Little Rock, AR 3:10 The genetics and epigenetics of neonatal abstinence syndrome D. Nielsen, Baylor College of Medicine, Houston, TX 3:35 Opioid addiction treatments during pregnancy and their potential effects on glial cell development and brain myelination C. Sato-Bigbee, Virginia Commonwealth University, Richmond, VA 4:00 Preclinical modeling of opioid addiction during pregnancy using self-administration E. Byrnes, Tufts University , North Grafton, MA- MASSACHUSETTS 4:25 DISCUSSANT: Clinical and basic science partnerships: The key to future therapeutic breakthroughs in NAS research L. Brents, University of Arkansas for Medical Sciences, Little Rock, AR ORAL COMMUNICATIONS 3 Outremont TRANSLATIONAL KAPPA-TILIZATION 5:00 - 6:00 PM Chairs: Drew Townsend and Thomas Prisinzano 5:00 Development of salvinorin A-based kappa opioid receptor agonists for drug abuse therapy Rachel Crowley1, Thomas Prisinzano2 , 1University of Kansas, Lawrence, KS, 2University of Kansas School of Pharmacy, Lawrence, KS 5 of 109 6/2/17, 3:34 PM CPDD Program https://www.xcdsystem.com/cpdd/printedProgram/program.cfm 5:15 Analgesic effects of kappa opioid receptor agonist 16-ethynyl salvinorin A in mice Kelly Paton1, Samuel Williamson2, Thomas Prisinzano3, Bronwyn Kivell1 , 1Victoria University of Wellington, Wellington, New Zealand, New Zealand, 2University of Kansas, Department of Medicinal Chemistry, Lawrence, KS, 3University of Kansas School of Pharmacy, Lawrence, KS 5:30 Effects of nalfurafine on oxycodone reinforcement and thermal antinociception: Modeling a candidate abuse-deterrent opioid analgesic in male rats Drew Townsend1, Jennifer Naylor2, S.